Reading Time: < 1 minute The cell-based breast milk aims to launch next year (Photo: Adobe. Do not use without permission)
Reading Time: < 1 minute

Bio tech startup TurtleTree Labs aims to ‘disrupt’ the ‘unsustainable’ dairy industry with its latest mission: lab-grown breast milk.

The Singapore-based company, which has received investment from the likes of Prince Khaled, aims to launch the product by next year.

‘The best nutritional value’

According to Green Queen, the cell-based human breast milk will start retailing at $26 (USD) per liter – with further details to be announced in April this year. 

Co-Founder Max Rye told the publication the company has ‘not come close to the nutritional value of real human mother’s milk’ just yet, but states its upcoming product will ‘have the best nutritional value that infants need to develop healthily’.

‘Reducing carbon footprint’

“TurtleTree Labs is recreating real milk inside a lab using the latest cutting edge innovation in biotech,” the organization’s website reads.

“Our focus on execution will disrupt this multi-billion dollar industry while reducing the carbon footprint on this planet. Our innovation will provide millions of access to safer, reliable and higher quality dairy products.”

Lab-grown breast milk not only provides an alternative to vegan mother’s unable to breast feed but also for orphaned babies, premature babies, and HIV+ mothers. 

Liam Gilliver

Liam is the Deputy Editor and Social Media Coordinator for Plant Based News. He has written for a number of top publications including Gay Times, Attitude Magazine, Oh Comely, and The Huffington Post - and is the author of 'We're Worried About Him'.